Abbott starts pivotal trial for mitral valve replacement device
Summary
The study is testing a device that Abbott executives believe can expand the mitral valve market.
More from MedTech Dive
Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansionAdvaMed Chair Mick Farrell shares his top priorities, challenges for the medtech industryLabcorp, Quest urge RESULTS Act passage as lab payment cuts loomStryker lowers 2026 guidance after slowdown in hip, knee procedures